By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit
www.amgen.com and follow us on www.twitter.com/amgen.


Key Statistics


Email:
Ownership: Public

Web Site: Amgen
Employees: 7,300+ Worldwide
Symbol: AMGN
 





Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax  Antibody phage display





Company News
Amgen (AMGN) Announces Voting Results Of Annual Meeting Of Stockholders 5/20/2016 7:02:30 AM
Amgen (AMGN) Highlights Data To Be Presented At 21st Congress Of The European Hematology Association 5/20/2016 6:48:47 AM
Amgen (AMGN) Data To Be Presented At ASCO 2016 Demonstrates More Insights Into Treatment Options For Patients 5/19/2016 7:27:09 AM
Amgen (AMGN) Researchers Discover Gene that Cuts Heart Attack Risk 5/19/2016 7:15:08 AM
Amgen (AMGN)'s Breakaway from Cancer Public Service Announcement Delivers Message That Education, Resources And Hope Are Essential In The Fight Against Cancer 5/18/2016 7:14:23 AM
3 Biotech Stocks Investors Should Pick Up in May 5/17/2016 7:09:10 AM
Evaluating Amgen (AMGN) and Sanofi (SNY)'s Individual Needs for Medivation (MDVN) 5/13/2016 7:00:04 AM
Amgen (AMGN) Commences Exchange Offers For Certain Series Of Outstanding Senior Notes From Exchange Eligible Holders 5/13/2016 6:12:11 AM
Hall of Fame Quarterback Joe Montana And Amgen (AMGN) Team Up To Launch Breakaway From Heart Disease To Make Heart Health A Priority 5/11/2016 8:29:04 AM
Medivation (MDVN) Takeover Saga Takes Another Turn, Rumored to Open Books to Amgen (AMGN) and Pfizer (PFE) 5/10/2016 7:57:09 AM
12345678910...
//-->